| Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors AL Walz, A Ooms, S Gadd, DS Gerhard, MA Smith, JMG Auvil, ... Cancer cell 27 (2), 286-297, 2015 | 318 | 2015 |
| Joint models for multivariate longitudinal and multivariate survival data YY Chi, JG Ibrahim Biometrics 62 (2), 432-445, 2006 | 274 | 2006 |
| Dysbiosis and alterations in predicted functions of the subgingival microbiome in chronic periodontitis ME Kirst, EC Li, B Alfant, YY Chi, C Walker, I Magnusson, GP Wang Applied and environmental microbiology 81 (2), 783-793, 2015 | 251 | 2015 |
| The high-dimension, low-sample-size geometric representation holds under mild conditions J Ahn, JS Marron, KM Muller, YY Chi Biometrika 94 (3), 760-766, 2007 | 213 | 2007 |
| Length of stay and total hospital charges of clipping versus coiling for ruptured and unruptured adult cerebral aneurysms in the Nationwide Inpatient Sample database 2002 to 2006 BL Hoh, YY Chi, MF Lawson, J Mocco, FG Barker Stroke 41 (2), 337-342, 2010 | 189 | 2010 |
| Addition of vincristine and irinotecan to vincristine, dactinomycin, and cyclophosphamide does not improve outcome for intermediate-risk rhabdomyosarcoma: a report from the … DS Hawkins, YY Chi, JR Anderson, J Tian, CAS Arndt, L Bomgaars, ... Journal of Clinical Oncology 36 (27), 2770-2777, 2018 | 167 | 2018 |
| The linkage between pediatric quality of life and health conditions: establishing clinically meaningful cutoff scores for the PedsQL IC Huang, LA Thompson, YY Chi, CA Knapp, DA Revicki, M Seid, ... Value in Health 12 (5), 773-781, 2009 | 154 | 2009 |
| Effect of weekend compared with weekday stroke admission on thrombolytic use, in-hospital mortality, discharge disposition, hospital charges, and length of stay in the … BL Hoh, YY Chi, MF Waters, J Mocco, FG Barker Stroke 41 (10), 2323-2328, 2010 | 149 | 2010 |
| Results of the first prospective multi-institutional treatment study in children with bilateral Wilms tumor (AREN0534): a report from the Children's Oncology Group P Ehrlich, YY Chi, MM Chintagumpala, FA Hoffer, EJ Perlman, ... Annals of surgery 266 (3), 470-478, 2017 | 148 | 2017 |
| Association of chromosome 1q gain with inferior survival in favorable-histology Wilms tumor: a report from the Children’s Oncology Group EJ Gratias, JS Dome, LJ Jennings, YY Chi, J Tian, J Anderson, P Grundy, ... Journal of Clinical Oncology 34 (26), 3189-3194, 2016 | 147 | 2016 |
| Stent-associated flow remodeling causes further occlusion of incompletely coiled aneurysms MF Lawson, WC Newman, YY Chi, JD Mocco, BL Hoh Neurosurgery 69 (3), 598-604, 2011 | 144 | 2011 |
| The effect of coiling versus clipping of ruptured and unruptured cerebral aneurysms on length of stay, hospital cost, hospital reimbursement, and surgeon reimbursement at the … BL Hoh, YY Chi, MA Dermott, PJ Lipori, SB Lewis Neurosurgery 64 (4), 614-621, 2009 | 138 | 2009 |
| A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study SL Spunt, L Million, YY Chi, J Anderson, J Tian, E Hibbitts, C Coffin, ... The Lancet Oncology 21 (1), 145-161, 2020 | 135 | 2020 |
| Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: a report from the Children's … E Hibbitts, YY Chi, DS Hawkins, FG Barr, JA Bradley, R Dasgupta, ... Cancer medicine 8 (14), 6437-6448, 2019 | 132 | 2019 |
| Treatment of stage IV favorable histology Wilms tumor with lung metastases: a report from the Children’s Oncology Group AREN0533 study DB Dix, NL Seibel, YY Chi, G Khanna, E Gratias, JR Anderson, EA Mullen, ... Journal of Clinical Oncology 36 (16), 1564-1570, 2018 | 126 | 2018 |
| Identification and preliminary characterization of ubiquitin C terminal hydrolase 1 (UCHL1) as a biomarker of neuronal loss in aneurysmal subarachnoid hemorrhage SB Lewis, R Wolper, YY Chi, L Miralia, Y Wang, C Yang, G Shaw Journal of neuroscience research 88 (7), 1475-1484, 2010 | 121 | 2010 |
| Randomized phase II trial of bevacizumab or temsirolimus in combination with chemotherapy for first relapse rhabdomyosarcoma: a report from the Children’s Oncology Group L Mascarenhas, YY Chi, P Hingorani, JR Anderson, ER Lyden, ... Journal of Clinical Oncology 37 (31), 2866-2874, 2019 | 114 | 2019 |
| Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group AHAG Ooms, S Gadd, DS Gerhard, MA Smith, JM Guidry Auvil, ... Clinical Cancer Research 22 (22), 5582-5591, 2016 | 113 | 2016 |
| Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: a report from the Children's Oncology Group ER Rudzinski, JR Anderson, YY Chi, JM Gastier‐Foster, C Astbury, ... Pediatric blood & cancer 64 (12), e26645, 2017 | 107 | 2017 |
| The need for reorientation toward cost-effective prediction: comments on'Evaluating the added predictive ability of a new marker: From area under the ROC curve to … S Greenland Statistics in medicine 27 (2), 199-206, 2008 | 103 | 2008 |
J. S. MarronUniversity of North CarolinaAdresse e-mail validée de unc.edu
